NO20004961D0 - Nye lokale anestesiforbindelser og anvendelser - Google Patents

Nye lokale anestesiforbindelser og anvendelser

Info

Publication number
NO20004961D0
NO20004961D0 NO20004961A NO20004961A NO20004961D0 NO 20004961 D0 NO20004961 D0 NO 20004961D0 NO 20004961 A NO20004961 A NO 20004961A NO 20004961 A NO20004961 A NO 20004961A NO 20004961 D0 NO20004961 D0 NO 20004961D0
Authority
NO
Norway
Prior art keywords
applications
local anesthetic
new local
anesthetic compounds
compounds
Prior art date
Application number
NO20004961A
Other languages
English (en)
Other versions
NO20004961L (no
Inventor
Sabine M Axt
Timothy J Church
Witold Hruzewicz
John R Jacobsen
Thomas E Jenkins
Yu-Hua Ji
Kevin J Judice
Original Assignee
Advanced Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Medicine Inc filed Critical Advanced Medicine Inc
Publication of NO20004961D0 publication Critical patent/NO20004961D0/no
Publication of NO20004961L publication Critical patent/NO20004961L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20004961A 1998-04-03 2000-10-02 Nye lokale anestesiforbindelser og anvendelser NO20004961L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8053198P 1998-04-03 1998-04-03
US12207599P 1999-03-01 1999-03-01
PCT/US1999/007263 WO1999051565A1 (en) 1998-04-03 1999-04-02 Novel local anesthetic compounds and uses

Publications (2)

Publication Number Publication Date
NO20004961D0 true NO20004961D0 (no) 2000-10-02
NO20004961L NO20004961L (no) 2000-10-02

Family

ID=26763633

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004961A NO20004961L (no) 1998-04-03 2000-10-02 Nye lokale anestesiforbindelser og anvendelser

Country Status (16)

Country Link
US (3) US6337423B1 (no)
EP (1) EP1066245A4 (no)
JP (1) JP2002510669A (no)
KR (1) KR20010034737A (no)
CN (1) CN1295558A (no)
AR (1) AR014809A1 (no)
AU (1) AU3464999A (no)
BR (1) BR9909377A (no)
CA (1) CA2315946A1 (no)
CO (1) CO5040088A1 (no)
HU (1) HUP0102831A2 (no)
IL (1) IL137411A0 (no)
NO (1) NO20004961L (no)
PE (1) PE20000354A1 (no)
PL (1) PL342991A1 (no)
WO (1) WO1999051565A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462034B1 (en) 1998-04-03 2002-10-08 Theravance, Inc. Local anesthetic compounds and uses
CO5040088A1 (es) * 1998-04-03 2001-05-29 Advanced Medicine Inc Nuevos compuestos y usos anestesicos locales
US6355637B1 (en) * 1999-10-01 2002-03-12 Advanced Medicine, Inc. Local anesthetic compounds
AU7847800A (en) 1999-10-15 2001-04-30 Mayo Foundation For Medical Education And Research Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
DE10161644A1 (de) * 2001-12-14 2003-06-26 Gruenenthal Gmbh N,N'-disubstituierte Piperazin-Verbindungen
US20050112183A1 (en) * 2003-11-25 2005-05-26 Galer Bradley S. Compositions and methods for treating neuropathic sensory loss
US7666914B2 (en) * 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
AU2006311954A1 (en) * 2005-11-02 2007-05-18 Icagen, Inc. Inhibitors of ion channels
TW200804288A (en) 2005-12-12 2008-01-16 Astrazeneca Ab Alkylsulphonamide quinolines
WO2009054916A2 (en) * 2007-10-19 2009-04-30 Nektar Therapeutics Al, Corporation Oligomer conjugates of lidocaine and its derivatives
WO2014170648A1 (en) 2013-04-19 2014-10-23 Astrazeneca Ab A nk3 receptor antagonist compound (nk3ra) for use in a method for the treatment of polycystic ovary syndrome (pcos)
EP3077365A1 (en) * 2013-12-05 2016-10-12 Elex Biotech, LLC Compounds for treatment of cardiac arrhythmias
CN105418489A (zh) * 2016-01-22 2016-03-23 江苏宝众宝达药业有限公司 一种布比卡因的合成方法
CN110092731B (zh) * 2018-01-31 2022-03-04 四川大学华西医院 长链胺取代的二甲基苯铵类化合物、制备、自组装结构及用途
CN110156666B (zh) * 2018-02-11 2022-04-12 四川大学华西医院 一种阳离子类化合物及其制备方法与用途
CN108514589A (zh) * 2018-06-28 2018-09-11 河南科技大学第附属医院 一种用于局部麻醉的中药麻醉剂
JP7558956B2 (ja) * 2019-02-01 2024-10-01 ウェストチャイナホスピタル、スーチョワンユニバーシティ 第四級アンモニウム塩系化合物およびその製造方法と使用
CN112574098B (zh) * 2019-09-30 2022-06-07 四川大学华西医院 一种酰胺化合物及其制备方法和用途
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
KR20250133471A (ko) 2020-02-18 2025-09-05 길리애드 사이언시즈, 인코포레이티드 항바이러스 화합물
TWI883391B (zh) 2020-02-18 2025-05-11 美商基利科學股份有限公司 抗病毒化合物
WO2022020651A1 (en) * 2020-07-22 2022-01-27 Fog Pharmaceuticals, Inc. Amino acids
WO2022037590A1 (zh) * 2020-08-17 2022-02-24 四川大学华西医院 一种用于麻醉的季铵盐类化合物及其制备方法和用途
CN111909039A (zh) * 2020-09-07 2020-11-10 江苏湘园化工有限公司 一种高位阻效应的脂肪族二元仲胺的制备方法
CA3216162A1 (en) 2021-04-16 2022-10-20 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
AU2022328698B2 (en) 2021-08-18 2025-02-20 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same
CN118851987A (zh) * 2023-04-27 2024-10-29 宜昌人福药业有限责任公司 一种季铵盐化合物、盐型及其应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB692332A (en) * 1950-07-18 1953-06-03 Geigy Ag J R Improvements relating to quaternary ammonium compounds, and their uses
DE1054462B (de) * 1955-10-27 1959-04-09 Espe Fabrik Pharm Praeparate G Verfahren zur Herstellung von lokalanaesthetisch wirksamen Polyaminoacetaniliden
DE1056619B (de) * 1956-11-29 1959-05-06 Bayer Ag Verfahren zur Herstellung von 4-Nitro-diarylaminen
DE1204226B (de) * 1963-12-10 1965-11-04 Boehringer Sohn Ingelheim Verfahren zur Herstellung von bisquaternaeren Zinnkomplexsalzen
NL137318C (no) 1964-06-09
GB1124837A (en) 1966-06-03 1968-08-21 Wyeth John & Brother Ltd Substituted anilides
US3898070A (en) 1971-07-29 1975-08-05 Ciba Geigy Corp Chelates for the control of metal-deficiency-phenomena in biological systems
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
JPS52139060A (en) * 1976-05-13 1977-11-19 Nippon Soda Co Ltd Imidazorium halides their preparation and fungicides for agriculture and horticulture
GB1574019A (en) * 1977-01-14 1980-09-03 Joullie International Sa Therapeutically useful 3,4,5-trimethoxybenzene derivatives
US4169106A (en) 1977-09-30 1979-09-25 Cooper Laboratories, Inc. Antiarrhythmic N,N'-bis(phenylcarbamoylalkyl)amidines
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US4597903A (en) 1984-08-21 1986-07-01 University Of Maryland Process for the direct preparation of N,N-disubstituted derivatives for 4,13-diaza-18-crown-6
GB8514209D0 (en) 1985-06-05 1985-07-10 Unilever Plc Catalyst additives
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US5719197A (en) 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5134232A (en) 1988-11-14 1992-07-28 The Regents Of The University Of California Fluorescent indicator dyes for alkali metal cations
JP2722250B2 (ja) 1989-05-30 1998-03-04 興和株式会社 新規なジアミン化合物及びこれを含有する脳機能障害改善剤
US4948906A (en) 1990-02-16 1990-08-14 Ethyl Corporation Trimethylaluminum process
CA2036781A1 (en) * 1990-02-22 1991-08-23 Fujio Antoku Triamine derivatives and their acid-addition salts
US5405975A (en) 1993-03-29 1995-04-11 Molecular Probes, Inc. Fluorescent ion-selective diaryldiaza crown ether conjugates
WO1992014697A1 (en) 1991-02-08 1992-09-03 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
WO1994001393A1 (fr) 1992-07-03 1994-01-20 The Green Cross Corporation Nouveau chelateur, complexe compose dudit chelateur et d'un atome metallique, et agent diagnostique renfermant ledit complexe
US5352705A (en) 1992-06-26 1994-10-04 Merck & Co., Inc. Inhibitors of farnesyl protein transferase
EP0582164B1 (en) 1992-07-31 1998-12-23 Bristol-Myers Squibb Company Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles
WO1997030019A1 (en) * 1996-02-13 1997-08-21 Shaman Pharmaceuticals, Inc. Aniline derivatives having antihyperglycemic activity
US5731438A (en) * 1996-08-01 1998-03-24 Isis Pharmaceuticals, Inc. N-(aminoalkyl)-and/or N-(amidoalkyl)-dinitrogen heterocycles
CO5040088A1 (es) * 1998-04-03 2001-05-29 Advanced Medicine Inc Nuevos compuestos y usos anestesicos locales

Also Published As

Publication number Publication date
WO1999051565A1 (en) 1999-10-14
BR9909377A (pt) 2000-12-05
JP2002510669A (ja) 2002-04-09
CA2315946A1 (en) 1999-10-14
EP1066245A1 (en) 2001-01-10
CO5040088A1 (es) 2001-05-29
EP1066245A4 (en) 2001-01-24
AU3464999A (en) 1999-10-25
US6337423B1 (en) 2002-01-08
IL137411A0 (en) 2001-07-24
PL342991A1 (en) 2001-07-16
KR20010034737A (ko) 2001-04-25
WO1999051565A9 (en) 1999-12-02
US6576791B1 (en) 2003-06-10
HUP0102831A2 (hu) 2001-12-28
AR014809A1 (es) 2001-03-28
US6495681B1 (en) 2002-12-17
CN1295558A (zh) 2001-05-16
PE20000354A1 (es) 2000-05-20
NO20004961L (no) 2000-10-02

Similar Documents

Publication Publication Date Title
NO20004961D0 (no) Nye lokale anestesiforbindelser og anvendelser
NO20032753D0 (no) Forbindelse og anvendelse derav
NO20010446D0 (no) Substituert anilidforbindelser og metoder
NO20016314L (no) Blandinger og fremgangsmåte for oljefeltapplikasjoner
DK2036581T3 (da) Sårforbindinger og egnede materialer til anvendelse deri
NO20022289L (no) Ny anvendelse og nye N-azabisykloamidderivater
NO20022334L (no) Ny sammensetning og anvendelse
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20006488D0 (no) Sammensetning og anvendelse
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
NO20004959L (no) Nye og forbedrede borefluider og additiver derfor
NO20010860D0 (no) Nye forbindelser
FI981247A0 (fi) Muuntaja
NO20003601D0 (no) Nye naftyl-substituerte og anilid-substituerte sulfonamider
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
NO20010861D0 (no) Nye forbindelser
NO983678D0 (no) Nye cefemforbindelser og farmasöytiske anvendelser derav
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO20030822D0 (no) Nye forbindelser og fremgangsmåter
NO20005857L (no) Nye blandinger
NO984829D0 (no) Operasjonsutstyr og bruks-fremgangsmÕte
NO20012943D0 (no) Nye heterocykliske forbindelser og farmasöytiske sammensetninger inneholdende det samme
DE69900802D1 (de) MnMgCuZn-Ferrit und dessen Verwendung
NO20004553L (no) Blandinger og fremgangsmÕter for oljefeltanvendelser
NO992690D0 (no) Nye calpainer, fremstilling og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application